Company profile: AnaBios
1.1 - Company Overview
Company description
- Provider of human-focused contract research services and products for biotech and pharma drug discovery, using ex vivo studies of human donor organs and tissues. Includes ethical human tissue and cell procurement, human primary cells and media, RIN analysis, custom tissue collection, cryopreserved human hepatocytes, and high-quality human heart tissue for cardiovascular preclinical research.
Products and services
- Cryopreserved Human Hepatocytes: Supplies cryopreserved human hepatocytes for disease modeling and genomic applications, available in suspension and plateable formats for use in compatible assay systems
- Human Heart Tissue for Drug Discovery: Delivers human heart tissue processed for high-RNA-integrity, supporting cardiovascular preclinical drug discovery and ex vivo assessment of human drug responses
- Human Tissue and Cell Procurement: Procures ethically-sourced human tissues and cells from consented U.S. donors for biological research, ensuring compliance with consent procedures and documented ethical sourcing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AnaBios
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
Perigord
HQ: Ireland
Website
- Description: Provider of best-in-class labeling artwork to life science companies, with unparalleled expertise in highly regulated sectors, and developer of the world’s only dedicated Pharmaceutical Artwork Management System, GLAMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perigord company profile →
Integrity Bio
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on biologics formulation and GMP fill-finish. Offers formulation, process development, clinical and commercial production; cGMP analytical testing (chromatography, mass spectrometry, NMR); batch release and stability testing; separation science; analytical method development/validation; consultative services. Specializes in hard-to-formulate liquid and lyophilized products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrity Bio company profile →
MedPharm
HQ: United Kingdom
Website
- Description: Provider of topical and transdermal product design and formulation development services, offering unique, cost-effective performance testing models to reduce risk and accelerate development for generic and proprietary pharmaceutical customers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedPharm company profile →
Batavia Biosciences
HQ: The Netherlands
Website
- Description: Provider of services accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost, including candidate selection, production of research materials, upstream and downstream process development, assay development, and product characterization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Batavia Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AnaBios
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AnaBios
2.2 - Growth funds investing in similar companies to AnaBios
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AnaBios
4.2 - Public trading comparable groups for AnaBios
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →